Niranjan Kanesa-thasan files SEC Form 4 disclosures for Icosavax, Inc.. They have made 3 open-market trades across 1 company since 2021, most recently 2024-02-19.
CIK 0001874021
1 open-market purchase totalling $100K since 2021, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICVX | 223,980 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2024-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICVX | SELL | 2023-12-20 | 2023-12-22 | $15.46 | $367K | +0.5% | -1.5% | N/A |
| ICVX | SELL · 10b5-1 | 2023-07-31 | 2023-08-01 | $8.86 | $29K | -8.8% | -9.2% | -27.3% |
| ICVX | SELL · 10b5-1 | 2023-02-13 | 2023-02-15 | $10.69 | $19K | -11.0% | -30.3% | -10.3% |
| ICVX | SELL | 2023-01-04 | 2024-01-05 | $15.70 | $3.3M | -0.3% | -2.4% | N/A |
| ICVX | SELL · 10b5-1 | 2022-07-29 | 2022-08-02 | $6.75 | $22K | +28.3% | -34.4% | -51.0% |
| ICVX | BUY | 2021-08-02 | 2021-08-02 | $15.00 | $100K | +29.5% | +55.4% | +13.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.